Clik here to view.
The Downside To Clinical Trials
As the practice of medicine has moved from a profession to an industrial undertaking, this most human of experiences has fallen prey to the dictates of the American business model. Patients are no...
View ArticleClik here to view.
Microarray, Gene Expression and Cell-Lines
There have been attempts to develop molecular-based tests to examine a broader range of chemotherapeutic drugs. New technologies for measuring the expression (biological activity) of literally...
View ArticleClik here to view.
Whole genome sequencing; not ready for prime time
A test of the utility of whole-genome sequencing (WGS) on 12 genetically healthy adults reveals several shortcomings, according to a study published in the March 12 issue of JAMA.read more
View ArticleClik here to view.
Why Do Cancer Surgeons Cure More Patients Than Medical Oncologists?
Robert A. Nagourney, M.D. Who does it really serve when a clinical trial involving 597 patients results in an increase in survival by 10 days? read more
View ArticleClik here to view.
New study helps to explain why breast cancer often spreads to the lung
New research led by Alison Allan, PhD, a scientist at Western University and the Lawson Health Research Institute, shows why breast cancer often spreads or metastasizes to the lung. Breast cancer is...
View ArticleClik here to view.
The Rising Cost of Cancer Research: Is It Necessary?
Robert A. Nagourney, M.D. read more
View ArticleClik here to view.
New Discoveries in Cancer and Heart Disease
Larry M. Weisenthal, M.D., Ph.D. MCED: A newly-discovered mechanism of endothelial cell death read more
View ArticleClik here to view.
Clik here to view.
Training the immune system to fight cancer
The potential to harness the body's immune system to fight cancer may finally prove itself on a large scale in the next couple of years. Scores of new immunotherapy vaccines and other immune system...
View ArticleClik here to view.
Top 10 Reasons Against Routine Genomic Profiling of Tumors in Patient Care
When they did comprehensive screening for gene mutations at MD Anderson, in a huge number of patients, they found an actionable target in 31%, but, of these 31%, only 10% responded to the targeted...
View Article